L. Bara

5.2k total citations · 1 hit paper
73 papers, 4.1k citations indexed

About

L. Bara is a scholar working on Surgery, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, L. Bara has authored 73 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 26 papers in Hematology and 23 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in L. Bara's work include Blood Coagulation and Thrombosis Mechanisms (24 papers), Heparin-Induced Thrombocytopenia and Thrombosis (18 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). L. Bara is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (24 papers), Heparin-Induced Thrombocytopenia and Thrombosis (18 papers) and Venous Thromboembolism Diagnosis and Management (18 papers). L. Bara collaborates with scholars based in France, United Kingdom and United States. L. Bara's co-authors include M Samama, François Cambien, Dominique Arveiler, Odette Poirier, Jean‐Pierre Cambou, Laurence Tiret, Alun Evans, Gérald Luc, Sylvain Ricard and Laure Lecerf and has published in prestigious journals such as Nature, Circulation and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

L. Bara

70 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction

1992 1.6k citations François Cambien, Odette Poirier et al. Nature profile →

Peers

Countries citing papers authored by L. Bara

Since Specialization

Citations

This map shows the geographic impact of L. Bara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Bara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Bara more than expected).

Fields of papers citing papers by L. Bara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Bara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Bara. The network helps show where L. Bara may publish in the future.

Co-authorship network of co-authors of L. Bara

This figure shows the co-authorship network connecting the top 25 collaborators of L. Bara. A scholar is included among the top collaborators of L. Bara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Bara. L. Bara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of UDP-glucuronyltransferase induction on zearalenone metabolism. 2008 ·(unknown), L. Bara, (unknown), (unknown), (unknown)	1
2	Determination of prothombinase activation after adding human purified prothrombin to human clot: comparison of hirudin, an activated factor II inhibitor, with DX9065a, an activated factor X inhibitor, on clot-associated thrombin and on prothrombin activation 2005 ·Blood Coagulation & Fibrinolysis ·(unknown), L. Bara, Hatem Fessi, Michel Meyer Samama	6
3	Correlation of Plasma Coagulation Parameters With Thromboprophylaxis, Patient Characteristics, and Outcome in the MEDENOX Study 2004 ·Archives of Pathology & Laboratory Medicine ·Louis Desjardins, L. Bara, Florent Boutitie, M Samama, Alexander T. Cohen, S. Combe, C Janbon, Alain Leizorovicz, Carl‐Gustav Olsson, Alexander G.G. Turpie	38
4	On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma 2003 ·Blood Coagulation & Fibrinolysis ·Grigoris Gerotziafas, Ismaı̈l Elalamy, François Depasse, Tahar Chakroun, L. Bara, (unknown), M Samama	6
5	Occurrence of thrombosis and haemorrhage, relationship with anti‐Xa, anti‐IIa activities, and D‐dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery 1999 ·British Journal of Haematology ·L. Bara, André Planès, Meyer‐Michel Samama	84
6	BIOCHEMICAL AND PHARMACOLOGIC RATIONALE FOR THE DEVELOPMENT OF A SYNTHETIC HEPARIN PENTASACCHARIDE 1997 ·Thrombosis Research ·Jeanine M. Walenga, Walter Jeske, L. Bara, M Samama, Jawed Fareed	79
7	A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery 1996 ·Blood Coagulation & Fibrinolysis ·Ismaı̈l Elalamy, (unknown), C Lecrubier, L. Bara, J. P. Marie, M Samama	19
8	Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbits 1994 ·Thrombosis Research ·(unknown), L. Bara, Marie-Françoise Bloch, M Samama	13
9	Factor VII activation and oral contraceptives 1993 ·Thrombosis Research ·Geneviève Plu‐Bureau, (unknown), L. Bara, A Malméjac, L Guize, M Samama	12
10	Comparative effects of enoxaparin and unfractionated heparin in healthy volunteers on prothrombin consumption in whole blood during coagulation, and release of tissue factor pathway inhibitor 1993 ·Thrombosis Research ·L. Bara, Marie-Françoise Bloch, (unknown), M Samama, F. Collignon, Armand Frydman, A. Uzan, J. Bouthier	51
11	Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction breakdown → 1992 ·Nature ·François Cambien, Odette Poirier, Laure Lecerf, Alun Evans, Jean‐Pierre Cambou, Dominique Arveiler, Gérald Luc, Jean‐Marie Bard, L. Bara, Sylvain Ricard, Laurence Tiret, Philippe Amouyel, François Alhenc‐Gelas, Florent Soubrier	1552
12	Pharmacokinetics and biodistribution of technetium 99m labelled standard heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteers 1991 ·British Journal of Haematology ·(unknown), N. Colas-Linhart, (unknown), (unknown), L. Bara, M. Samama, (unknown), F. Imbault, A. Uzan	30
13	Anti Xa activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgery 1991 ·Thrombosis Research ·M Samama, S. Combe, M.H. Horellou, (unknown), J B Truc, J. Conard, Philippe Girard, L. Bara, (unknown)	10
14	Factor VII activation and menopausal status 1990 ·Thrombosis Research ·Pierre‐Yves Scarabin, Claire Bonithon‐Kopp, L. Bara, A Malméjac, L Guize, M Samama	46
15	In vitro effect on heptest® of low molecular weight heparin fractions and preparations with various anti-IIa and anti-Xa activities 1990 ·Thrombosis Research ·L. Bara, (unknown), M Samama	25
16	The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma 1990 ·Thrombosis Research ·(unknown), L. Bara, M Samama	16
17	The inhibition of the generation of thrombin and the antithrombotic effect of a pentasaccharide with sole anti-factor Xa activity 1988 ·Thrombosis Research ·Jeanine M. Walenga, L. Bara, Maurice Petitou, M Samama, Jawed Fareed, J Choay	57
18	The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg 1988 ·The Journal of Clinical Pharmacology ·Armand Frydman, L. Bara, (unknown), M. Woler, (unknown), Michel Meyer Samama	148
19	Relationship between Biological Activity and Concentration of a Low-Molecular-Weight Heparin (PK 10169) and Unfractionated Heparin after Intravenous and Subcutaneous Administration 1986 ·Pathophysiology of Haemostasis and Thrombosis ·J. Dawes, L. Bara, (unknown), M Samama	63
20	Partial Reversal of Low Molecular Weight Heparin (PK 10169) Anti-Xa Activity by Protamine Sulfate: In vitro and in vivo Study during Cardiac Surgery with Extracorporeal Circulation 1986 ·Pathophysiology of Haemostasis and Thrombosis ·(unknown), (unknown), L. Bara, (unknown), B. Abry, P. Guibourt, (unknown), (unknown), A Carpentier, M Samama	83

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact